Emerging Infectious Disease and HIV Scholars Program at Brown University
Project Number5R25AI140490-07
Former Number5R25AI140490-05
Contact PI/Project LeaderCHIANG, SILVIA SHINPEI
Awardee OrganizationBROWN UNIVERSITY
Description
Abstract Text
The Emerging Infectious Disease and HIV Scholars Program (EIDS) program seeks to develop
a physician-scientist workforce focused on clinical research to inform practical responses to HIV
and associated infections over the next decades. The Alpert Medical School of Brown University
has incorporated a Master of Science with specific coursework to provide an educational
foundation for clinical research with a dedicated research block. The program offers financial
support for pilot research projects and appropriate mentors will be assigned to guide scholars.
Scholars in medical school will attend a relevant professional conference each year and
program faculty and mentors will provide supplemental networking opportunities at these
meetings. The program will work closely with the Rhode Island Department of Health to engage
trainees in the investigation of ongoing epidemics in Rhode Island, such as HIV, COVID-19,
monkey pox, hepatitis C, and escalating sexually transmitted infections including syphilis.
In the first four years, we enrolled and supported 66 scholars who completed clinical research
projects resulting in 72 abstracts and 31 publications. 25 out of 66 scholars (39%) were from
groups identified as underrepresented in the biomedical, clinical, behavioral, and social
sciences (URM utilizing the NIH definition).
This grant will continue to inspire, train, support, and retain a community of scholars to serve as
“microbes hunters”. Specific Aim 1: Inspire future physician-scientists to rapidly address
challenges of HIV associated infections and emerging epidemics. Specific Aim 2: Train future
physician-scientists. Over the course of four years, medical students will complete coursework
leading to a Master in Science degree. Specific Aim 3: Support future physician-scientists. All
scholars will have access to resources to develop an independent research proposal. Support
in clinical research tools, biostatistics, analysis, abstract development, and manuscript
preparation will be provided through tailored coursework and program faculty, staff, and
mentors, and funds will be available for scholars and program faculty and mentors to attend
appropriate scientific conferences.
Specific Aim 4: Retain the community of scholars throughout training. All aspects of the
program will be evaluated on an ongoing basis in order to determine acceptability, relevance,
and value of each component of the training program. Outcomes of interest include research
project development and completion, abstract presentation and manuscript publication, and
long-term engagement in clinical research related to emerging infectious disease.
Public Health Relevance Statement
The Emerging Infectious Disease and HIV Scholars at Brown University program is a
collaboration between the Alpert Medical School of Brown University, the affiliated hospitals,
and the Rhode Island Department of Health. The program seeks to develop a physician-
scientist workforce focused on clinical research to inform practical responses to HIV and
associated infections the important role of clinical research, particularly among marginalized
communities, to help end the HIV epidemic. This program is committed to training scholars
during medical school, including a Masters of Science and a mentored clinical research project.
Scholars will be inspired, trained, and supported as “microbe hunters” to respond to the various
challenges of HIV and emerging epidemics.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AddressAwardBehavioral SciencesBiometryCOVID-19Clinical ResearchClinical SciencesCollaborationsCommunitiesDataDedicationsDevelopmentDiagnosticDiseaseDisease OutbreaksEbolaEducationEducational process of instructingEmerging Communicable DiseasesEnrollmentEpidemicEthicsFacultyFinancial SupportFoundationsFundingFutureGoalsGrantHIVHIV/AIDSHealthHepatitis CHospitalsHuman Papilloma Virus-Related Malignant NeoplasmInfectionInvestigationManuscriptsMaster of ScienceMedicalMedical ResidencyMedical StudentsMentorsMentorshipMicrobeMonkeypoxMultidrug-Resistant TuberculosisOutcomePhasePhysiciansPreparationPreventionPublicationsPublishingReapplicationResearchResearch PersonnelResearch Project GrantsResearch ProposalsResourcesRhode IslandRoleScholars ProgramScienceScientistSevere Acute Respiratory SyndromeSexually Transmitted DiseasesSocial SciencesStructureSyphilisTimeTrainingTraining ProgramsUnited States National Institutes of HealthUniversitiesVaccinesWorkZIKAcombatexperiencefallshands on researchinterestmarginalized communitymedical schoolsmeetingsmen who have sex with mennew epidemicprogramsresponsesymposiumtooltreatment strategy
National Institute of Allergy and Infectious Diseases
CFDA Code
855
DUNS Number
001785542
UEI
E3FDXZ6TBHW3
Project Start Date
01-August-2018
Project End Date
31-July-2028
Budget Start Date
01-August-2024
Budget End Date
31-July-2025
Project Funding Information for 2024
Total Funding
$368,196
Direct Costs
$348,274
Indirect Costs
$19,922
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Allergy and Infectious Diseases
$368,196
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R25AI140490-07
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R25AI140490-07
Patents
No Patents information available for 5R25AI140490-07
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R25AI140490-07
Clinical Studies
No Clinical Studies information available for 5R25AI140490-07
News and More
Related News Releases
No news release information available for 5R25AI140490-07
History
No Historical information available for 5R25AI140490-07
Similar Projects
No Similar Projects information available for 5R25AI140490-07